Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
53 /100
HIGH RISK
Score updated Oct 13, 2026

LENZ — LENZ Therapeutics, Inc. Dilution Risk Tracker

Track LENZ dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LENZ — Get alerts when the score changes →

As of October 13, 2026, LENZ Therapeutics, Inc. (LENZ) has a DilutionWatch DilutionScore of 53/100, rated HIGH dilution risk. LENZ Therapeutics, Inc. has a market capitalization of $113.43M, 31.42M shares outstanding, 148 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
31
💰 Cash Runway
85
📊 Float Risk
55
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 17%
💰 Capital Raise model 35%
• Low cash runway: 3 months remaining
🔔 Track LENZ — Get forecast alerts →

Market Data

Market Cap$113.43M
Shares Outstanding31.42M
Float18.48M
Cash$24.21M
Debt$673.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore53/100DilutionWatch score record
Shares Outstanding31.42MVerified float table or market cache
Public Float18.48MVerified float table or market cache
Market Cap$113.43MMarket data cache
Cash Runway3.1 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 4, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 0.2% shares (2026Q1 vs prior)
148 institutional holders · 36.01M shares
#1 RA CAPITAL MANAGEMENT, L.P. 4.18M shares
#2 Alpha Wave Global, LP 3.61M shares
#3 FMR LLC 3.60M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest10.56M
Days to Cover13.8
% of Float57.1%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-24
xbrl XBRL WARRANT 2026-03-24
4 INSIDER TRANSACTION 2026-01-06
4 INSIDER TRANSACTION 2026-01-06
4 INSIDER TRANSACTION 2026-01-06
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual LENZ Dilution Snapshot

LENZ Therapeutics, Inc. (LENZ) has a DilutionScore of 53/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

LENZ's DilutionScore has held steady at 53/100 (High risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202653/100HIGH89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

LENZ shares outstanding have increased 0.2% from 31.29M (Mar 2026) to 31.35M (Apr 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Apr 11, 202631.35M18.48M▼ 7.94%
Apr 03, 202631.35M20.08M▼ 0.20%
Mar 27, 202631.35M20.12M▲ 0.11%
Mar 26, 202631.29M20.09M▲ 0.21%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track LENZ Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment LENZ files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking LENZ — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for LENZ
LENZ FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.